Sangamo Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good morning, everyone, and thank you for joining us for the fireside chat for Sangamo Therapeutics. A quick note before we get started. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Very pleased this morning to be joined by the CEO of Sangamo, Sandy Macrae. And Sandy, I'll turn it over to you. And perhaps we can maybe just get a brief overview of Sangamo before we start talking, going into some Q&A.
Good morning, Ashwin, and thank you for introducing me, and it's a pleasure to be here with Morgan Stanley. And it's a pleasure to present Sangamo Therapeutics. Sangamo is a fascinating company. It's a genomic medicines company with 3 medicines
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |